Publicaciones (86) Publicaciones en las que ha participado algún/a investigador/a

2015

  1. A Zn azelate MOF: Combining antibacterial effect

    CrystEngComm, Vol. 17, Núm. 2, pp. 456-462

  2. Alterations in brain leptin signalling in spite of unchanged CSF leptin levels in Alzheimer's disease

    Aging Cell, Vol. 14, Núm. 1, pp. 122-129

  3. Antiproliferative effect of phenylethanoid glycosides from Verbena officinalis L. on Colon Cancer Cell Lines

    LWT, Vol. 63, Núm. 2, pp. 1016-1022

  4. Antitumoral-Lipid-Based nanoparticles: A platform for future application in osteosarcoma therapy

    Current Pharmaceutical Design, Vol. 21, Núm. 42, pp. 6104-6124

  5. Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: The challenge ahead

    Carcinogenesis, Vol. 36, pp. S254-S296

  6. Assessment of DNA damage using comet assay in middle-aged overweight/obese subjects after following a hypocaloric diet supplemented with cocoa extract

    Mutagenesis, Vol. 30, Núm. 1, pp. 139-146

  7. Assessment of total (Free and Bound) phenolic compounds in spent coffee extracts

    Journal of Agricultural and Food Chemistry, Vol. 63, Núm. 17, pp. 4327-4334

  8. Assessment of β-lapachone loaded in lecithin-chitosan nanoparticles for the topical treatment of cutaneous leishmaniasis in L. major infected BALB/c mice

    Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 11, Núm. 8, pp. 2003-2012

  9. Can pentylenetetrazole and maximal electroshock rodent seizure models quantitatively predict antiepileptic efficacy in Humans?

    Seizure, Vol. 24, Núm. C, pp. 21-27

  10. Casein nanoparticles as carriers for the oral delivery of folic acid

    Food Hydrocolloids, Vol. 44, pp. 399-406

  11. Causes of genome instability: The effect of low dose chemical exposures in modern society

    Carcinogenesis, Vol. 36, pp. S61-S88

  12. Cetuximab-oxaliplatin-liposomes for epidermal growth factor receptor targeted chemotherapy of colorectal cancer

    Journal of Controlled Release, Vol. 210, pp. 26-38

  13. Chronic mild stress and imipramine treatment elicit opposite changes in behavior and in gene expression in the mouse prefrontal cortex

    Pharmacology Biochemistry and Behavior, Vol. 135, pp. 227-236

  14. Chronic stress and antidepressant induced changes in Hdac5 and Sirt2 affect synaptic plasticity

    European Neuropsychopharmacology, Vol. 25, Núm. 11, pp. 2036-2048

  15. Contribution of dopamine to mitochondrial complex i inhibition and dopaminergic deficits caused by methylenedioxymethamphetamine in mice

    Neuropharmacology, Vol. 93, pp. 124-133

  16. Controlled Release, Intestinal Transport, and Oral Bioavailablity of Paclitaxel Can be Considerably Increased Using Suitably Tailored Pegylated Poly(Anhydride) Nanoparticles

    Journal of Pharmaceutical Sciences, Vol. 104, Núm. 9, pp. 2877-2886

  17. Conventional formulations and emerging delivery systems for the topical treatment of Cutaneous Leishmaniasis

    Therapeutic Delivery

  18. Critical factors to be considered when testing nanomaterials for genotoxicity with the comet assay

    Mutagenesis, Vol. 30, Núm. 1, pp. 85-88

  19. Deciphering the Non-Equivalence of Serine and Threonine O-glycosylation Points: Implications for Molecular Recognition of the Tn Antigen by an anti-MUC1 Antibody

    Angewandte Chemie International, Vol. 54, Núm. 34, pp. 9830

  20. Decreased levels of guanosine 3', 5'-monophosphate (cGMP) in cerebrospinal fluid (CSF) are associated with cognitive decline and amyloid pathology in Alzheimer's disease

    Neuropathology and Applied Neurobiology, Vol. 41, Núm. 4, pp. 471-482